Phio Pharmaceuticals Corp.

PHIO · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 6 employees
332
SEC Filings
$1.03
Close 2026-09-11
6
Employees

Business Summary

Phio Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company developing cancer immunotherapies using its proprietary INTASYL small interfering RNA (siRNA) gene silencing technology. INTASYL enables self-delivering RNAi compounds without specialized formulations or delivery systems. Lead compound PH-762 targets PD-1 and is in a Phase 1b clinical trial for cutaneous squamous cell carcinoma, melanoma, and Merkel cell carcinoma. PH-894 targets BRD4 with a dual mode of action. The company operates as a single segment focused on immuno-oncology.

Latest Stock Quote

PHIO 2026-09-11 $1.03 O:$1.03 H:$1.05 L:$1.025 Vol:0.1M VWAP:$1.0385
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001437749-26-007078EDGAR47K words
2025-03-312024-12-310001683168-25-002134EDGAR50K words
2024-04-012023-12-310001683168-24-002021EDGAR44K words
2023-03-222022-12-310001683168-23-001678EDGAR46K words
2022-03-222021-12-310001683168-22-001833EDGAR—
2021-03-252020-12-310001683168-21-001062EDGAR—
2020-03-262019-12-310001683168-20-000969EDGAR—
2019-03-272018-12-310001683168-19-000795EDGAR—
2018-03-262017-12-310001193125-18-096053EDGAR—
2017-03-302016-12-310001193125-17-102730EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001437749-26-026271EDGAR15K words
2025-11-132025-09-300001437749-25-034857EDGAR18K words
2025-08-142025-06-300001683168-25-006174EDGAR18K words
2025-05-152025-03-310001683168-25-003719EDGAR16K words
2024-11-142024-09-300001683168-24-008120EDGAR16K words
2024-08-142024-06-300001683168-24-005706EDGAR15K words
2024-05-092024-03-310001683168-24-003175EDGAR12K words
2023-11-092023-09-300001683168-23-007809EDGAR13K words
2023-08-102023-06-300001683168-23-005514EDGAR13K words
2023-05-112023-03-310001683168-23-003213EDGAR11K words
2022-11-102022-09-300001683168-22-007528EDGAR—
2022-08-112022-06-300001683168-22-005565EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-280001437749-26-031337EDGAR1K words
2026-09-140001437749-26-030236EDGAR1K words
2026-08-060001437749-26-026275EDGAR2K words
2026-07-210001437749-26-023916EDGAR1K words
2026-03-300001437749-26-010164EDGAR1K words
2026-03-050001437749-26-007071EDGAR2K words
2026-02-180001437749-26-004542EDGAR1K words
2026-02-100001437749-26-003575EDGAR1K words
2026-01-200001437749-26-001500EDGAR1K words
2025-12-230001437749-25-038607EDGAR1K words

332 total filings indexed. 300 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

immuno-oncology cutaneous-squamous-cell-carcinoma-(cscc) melanoma merkel-cell-carcinoma adoptive-cell-therapy-(act) current-good-manufacturing-practices-(cgmp) rna-interference-(rnai) small-interfering-rna-(sirna) phosphorothioate-chemistry

Company Identity

CIK0001533040
TickerPHIO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.phiopharma.com
Listed2012-05-10

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: f7e1f1227585a8250b7a2fef1d38c7e9cc8e3f06905ef6043a1e1e4648bd33cd
parent: 569d75428d1ba164a029622803255888862900a18db4f1d58f06c9bbb5cdbb9d
content hash: a6bc3fc3b3aeb4ad4c49a9cfdb5a80bba39912069d46a6b2bcb07efef2190344
signed: 2026-09-29T19:02:41.755Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up PHIO using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on PHIO, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/PHIO (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.